Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Five Prime Therapeutics Inc patents


Recent patent applications related to Five Prime Therapeutics Inc. Five Prime Therapeutics Inc is listed as an Agent/Assignee. Note: Five Prime Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Five Prime Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Five Prime Therapeutics Inc-related inventors


Combination therapy for cancer

Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (csf1r) in combination with one or more immune stimulating agents are provided.. . ... Five Prime Therapeutics Inc

Slamf1 antagonists and uses thereof

Methods of identifying and using slamf1 antagonists are provided.. . ... Five Prime Therapeutics Inc

Fgfr1 extracellular domain combination therapies

Methods of treating cancer comprising administering a fibroblast growth factor receptor 1 (fgfr1) extracellular domain (ecd) and/or an fgfr1 ecd fusion molecule in combination with at least one additional therapeutic agent selected from docetaxel, paclitaxel, vincristine, carboplatin, cisplatin, oxaliplatin, doxorubicin, 5-fluorouracil (5-fu), leucovorin, pemetrexed, and bevacizumab are provided. Dosage packs comprising an fgfr1 ecd and/or an fgfr1 ecd fusion molecule and/or at least one additional therapeutic agent selected from docetaxel, paclitaxel, vincristine, carboplatin, cisplatin, oxaliplatin, doxorubicin, 5-fluorouracil (5-fu), leucovorin, pemetrexed, and bevacizumab are also provided. ... Five Prime Therapeutics Inc

Compositions and methods of treating disease with fgfr fusion proteins

The invention provides fgfr fusion proteins, methods of making them, and methods of using them to treat proliferative disorders, including cancers and disorders of angiogenesis. The fgfr fusion molecules can be made in cho cells and may comprise deletion mutations in the extracellular domains of the fgfrs which improve their stability. ... Five Prime Therapeutics Inc

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r) are provided. Such methods include, but are not limited to, methods of treating rheumatoid arthritis.. ... Five Prime Therapeutics Inc

Antibodies that bind colony stimulating factor 1 receptor (csf1r)

Antibodies that bind csf1r are provided. Antibody heavy chains and light chains that are capable of forming antibodies that bind csf1r are also provided. ... Five Prime Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Five Prime Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Five Prime Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###